EX-10.1



 Exhibit 10.1 

EXECUTION COPY 

$500,000,000 
 EXCO Resources,
Inc. 
 8.500% Senior Notes due 2022 

Underwriting Agreement 

April 11, 2014 
 J.P. Morgan Securities LLC

     As Representative of the 

    several Underwriters listed 

    in Schedule 1 hereto 
 c/o J.P. Morgan
Securities LLC 
 383 Madison Avenue 
 New York, New York 10179

 Ladies and Gentlemen: 
 EXCO Resources,
Inc., a Texas corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”),
$500,000,000 principal amount of its 8.500% Senior Notes due 2022 (the “Securities”). The Securities will be issued pursuant to an Indenture dated as of September 15, 2010, as amended (the “Base Indenture”) among the
Company, the guarantors listed on Schedule 2 hereto (the “Guarantors”) and Wilmington Trust Company, as trustee (the “Trustee”), as supplemented by the Third Supplemental Indenture to be dated as of the Closing Date (as defined
herein) (the “Third Supplemental Indenture” and together with the Base Indenture, the “Indenture”) and will be guaranteed on an unsecured senior basis by each of the Guarantors (the “Guarantees”). 

Each of the Company and the Guarantors hereby confirms its agreement with the several Underwriters concerning the purchase and sale of the
Securities, as follows: 
 1. Registration Statement. The Company has prepared and filed with the Securities and Exchange Commission
(the “Commission”) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Securities Act”), an automatic shelf registration statement on Form S-3 (File
No. 333-195126), including a prospectus, relating to the Securities. Such registration statement, as amended at the time it becomes effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities
Act to be part of the registration statement at the time of its effectiveness (“Rule 430 Information”), is referred to herein as the “Registration Statement”; and as used herein, 








 
the term “Preliminary Prospectus” means each prospectus included in such registration statement (and any amendments thereto) before it becomes effective, any prospectus filed with the
Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at the time of its effectiveness that omits Rule 430 Information, and the term “Prospectus” means the prospectus in the
form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Securities. If the Company has filed an abbreviated registration statement pursuant to Rule
462(b) under the Securities Act (the “Rule 462 Registration Statement”), then any reference herein to the term “Registration Statement” shall be deemed to include such Rule 462 Registration Statement. Any reference in this
Agreement to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the
effective date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may be and any reference to “amend”, “amendment” or “supplement” with respect to the Registration
Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder
(collectively, the “Exchange Act”) that are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus. 

At or prior to the time when sales of the Securities were first made (the “Time of Sale”), the Company had prepared the following
information (collectively, the “Time of Sale Information”): a Preliminary Prospectus dated April 8, 2014, and each “free-writing prospectus” (as defined pursuant to Rule 405 under the Securities Act) listed on Annex B
hereto. 
 The Company intends to use the proceeds of the offering of the Securities to repay in full all outstanding term loan borrowings
under the Amended and Restated Credit Agreement, dated as of July 31, 2013, among EXCO Resources, Inc., certain guarantors party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (as amended, the
“Credit Agreement”) and a portion of the revolving loan borrowings under the Credit Agreement, and to pay related fees and expenses. 

2. Purchase of the Securities by the Underwriters. (a) The Company agrees to issue and sell the Securities to the several
Underwriters as provided in this Agreement, and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the
Company the respective principal amount of Securities set forth opposite such Underwriter’s name in Schedule 1 hereto at a price equal to 98.25% of the principal amount thereof plus accrued interest, if any, from April 16, 2014 to the
Closing Date (as defined below). Capital One Securities, Inc., acting as a “qualified independent underwriter” within the meaning of Rule 5121 of the Financial Industry Regulatory Authority, Inc. (“FINRA”) has participated in the
preparation of the Preliminary Prospectus and has exercised the usual standards of due diligence with respect thereto. The Company will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as
provided herein. 

  
 2 








 (b) Each of the Company and the Guarantors hereby understands that the Underwriters intend to
make a public offering of the Securities as soon after the effectiveness of this Agreement as in the judgment of the Representative is advisable, and initially to offer the Securities on the terms set forth in the Time of Sale Information. Each of
the Company and the Guarantors acknowledges and agrees that the Underwriters may offer and sell Securities to or through any affiliate of an Underwriter and that any such affiliate may offer and sell Securities purchased by it to or through any
Underwriter. 
 (c) Payment for and delivery of the Securities will be made at the offices of Simpson Thacher & Bartlett LLP, 425
Lexington Avenue, New York, New York, at 10:00 A.M., New York City time, on April 16, 2014, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representative and the Company
may agree upon in writing. The time and date of such payment and delivery is referred to herein as the “Closing Date”. 
 (d)
Payment for the Securities shall be made by wire transfer in immediately available funds to the account(s) specified by the Company to the Representative against delivery to the nominee of The Depository Trust Company (“DTC”), for the
account of the Underwriters, of one or more global notes representing the Securities (collectively, the “Global Note”), with any transfer taxes payable in connection with the sale of the Securities duly paid by the Company. The Global Note
will be made available for inspection by the Representative not later than 1:00 P.M., New York City time, on the business day prior to the Closing Date. 

(e) Each of the Company and the Guarantors acknowledges and agrees that the Underwriters are acting solely in the capacity of an arm’s
length contractual counterparty to the Company and the Guarantors with respect to the offering of Securities contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to,
or an agent of, the Company, the Guarantors or any other person. Additionally, neither the Representative nor any other Underwriter is advising the Company, the Guarantors or any other person as to any legal, tax, investment, accounting or
regulatory matters in any jurisdiction. The Company and the Guarantors shall consult with their own advisors concerning such matters and shall be responsible for making their own independent investigation and appraisal of the transactions
contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company or the Guarantors with respect thereto. Any review by the Underwriters of the Company, the Guarantors, the transactions contemplated hereby or other
matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company, the Guarantors or any other person. 

  
 3 








 3. Representations and Warranties of the Company and the Guarantors. The Company and the
Guarantors jointly and severally represent and warrant to each Underwriter that: 
 (a) Preliminary Prospectus. No stop order
preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time of filing thereof, complied in all material respects with the Securities Act and did not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided
that neither the Company nor any of the Guarantors make any representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in
writing by such Underwriter through the Representative expressly for use in any Preliminary Prospectus. 
 (b) Time of Sale
Information. The Time of Sale Information, at the Time of Sale did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; provided that neither the Company nor any of the Guarantors make any representation or warranty with respect to any statements or omissions made in reliance upon and in
conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in the Preliminary Prospectus, the Time of Sale Information or the Prospectus. No statement
of material fact included in the Prospectus has been omitted from the Time of Sale Information and no statement of material fact included in the Time of Sale Information that is required to be included in the Prospectus has been omitted therefrom.

 (c) Issuer Free Writing Prospectus. The Company and the Guarantors (including their agents and representatives, other than the
Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any “written communication” (as defined in Rule 405 under the
Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company and the Guarantors or their agents and representatives (other than a communication referred to in clauses
(i), (ii) and (iii) below) an “Issuer Free Writing Prospectus”) other than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act,
(ii) the Preliminary Prospectus, (iii) the Prospectus, (iv) the documents listed on Annex B which constitute part of the Time of Sale Information and (v) any electronic road show or other written communications, in each case
approved in writing in advance by the Representative. Each such Issuer Free Writing Prospectus complied in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the
Securities Act (to the extent required thereby) and, when taken together with the Preliminary Prospectus filed prior to the first use of such Issuer Free 

  
 4 








 
Writing Prospectus, did not at the Time of Sale, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided that neither the Company nor any of the Guarantors make any representation or warranty with respect to any statements or omissions made
in each such Issuer Free Writing Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in any Issuer Free
Writing Prospectus. 
 (d) Registration Statement and Prospectus. The Registration Statement is an “automatic shelf registration
statement” as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use of such registration statement or
any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No stop order suspending the effectiveness of the Registration Statement has been issued by the Commission and no proceeding
for that purpose or pursuant to Section 8A of the Securities Act against the Company or related to the offering has been initiated or, to the knowledge of the Company and the Guarantors, threatened by the Commission; as of the applicable
effective date of the Registration Statement and any amendment thereto, the Registration Statement complied and will comply in all material respects with the Securities Act and the Trust Indenture Act of 1939, as amended, and the rules and
regulations of the Commission thereunder (collectively, the “Trust Indenture Act”), and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date, the Prospectus will not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that neither the Company nor any of the Guarantors make
any representation or warranty with respect to (i) that part of the Registration Statement that constitutes the Statement of Eligibility and Qualification (Form T-1) of the Trustee under the Trust Indenture Act or (ii) any statements or
omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in the Registration Statement and the Prospectus and
any amendment or supplement thereto. 
 (e) Incorporated Documents. The documents incorporated by reference in each of the
Registration Statement, the Prospectus and the Time of Sale Information, when filed with the Commission conformed in all material respects with the requirements of the Exchange Act and did not contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by


  
 5 








 
reference in the Registration Statement, the Prospectus or the Time of Sale Information, when such documents either become effective or are filed with the Commission, as the case may be, will
conform in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading. 
 (f) Financial
Statements. The financial statements of each of the Company, the Acquired Chesapeake Oil and Natural Gas Properties (the “Acquired Chesapeake Properties”) and TGGT Holdings, LLC (“TGGT”) included or incorporated by reference
in each of the Registration Statement, the Time of Sale Information and the Prospectus, together with the related notes and schedules, comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as
applicable, and present fairly in all material respects the consolidated financial position of the Company, the Acquired Chesapeake Properties and TGGT, as applicable, as of the dates indicated and the consolidated results of operations and cash
flows of the Company and its subsidiaries, the Acquired Chesapeake Properties and TGGT, as applicable, for the periods specified and have been prepared in compliance in all material respects with the requirements of the Exchange Act and in
conformity with generally accepted accounting principles (“GAAP”) applied on a consistent basis throughout the periods covered thereby (except, with respect to any unaudited financial statements, for the absence of customary year-end
adjustments) and the supporting schedules included or incorporated by reference in each of the Registration Statement, the Prospectus and the Time of Sale Information present fairly the information required to be stated therein. The other financial
and accounting data included or incorporated by reference in each of the Registration Statement, the Time of Sale Information and the Prospectus, has been derived from the accounting records of the Company and present fairly the information shown
therein, in all material respects; and the pro forma financial information and the related notes thereto included or incorporated by reference in each of the Registration Statement, the Time of Sale Information and the Prospectus have
been prepared in accordance with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and the assumptions underlying such pro forma financial information are reasonable and are set forth in, or
incorporated by reference in, each of the Registration Statement, the Time of Sale Information and the Prospectus. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement,
the Prospectus and the Time of Sale Information fairly presents the information called for in all material respects and is prepared in accordance with the Commission’s rules and guidelines applicable thereto. 

(g) No Material Adverse Change. Since the date of the most recent financial statements of the Company included or incorporated by
reference in each of the Registration Statement, the Time of Sale Information and the Prospectus, and except as may be otherwise stated or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus,
there has not been (A) any change in 

  
 6 








 
the capital stock or material change in the long-term debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by
the Company on any class of capital stock, or any material adverse change, or any development involving a prospective material adverse change, financial or otherwise, in or affecting in the business, properties, prospects, regulatory environment,
results of operations or condition (financial or otherwise) of the Company and its subsidiaries, taken as a whole, except for (i) the exercise of outstanding stock options pursuant to equity incentive plans as such equity incentive plans are
disclosed in the Registration Statement, the Time of Sale Information and the Prospectus and (ii) the Company’s declaration of a $0.05 per share dividend on March 10, 2014 and the payment of such dividend, (B) any transaction
entered into by the Company or any of its subsidiaries, which is material to the Company and its subsidiaries, taken as a whole, or (C) any obligation, contingent or otherwise, directly or indirectly, incurred by the Company or any of its
subsidiaries, which is material to the Company and its subsidiaries, taken as a whole, and (D) except, as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (defined below) on the Company and
its subsidiaries taken as a whole, none of the Company or any of its subsidiaries has sustained any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor
disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority. 
 (h)
Organization and Good Standing. The Company, each of its subsidiaries and each of the entities in which the Company, directly or indirectly, owns fifty-percent (50%) or less (the “Joint Ventures”) have been duly organized and
are validly existing and in good standing under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing in each jurisdiction in which their respective ownership or lease of property or
the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the businesses in which they are engaged, except where the failure to be so
qualified, in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial position, results of operations or prospects of the Company
and its subsidiaries taken as a whole or on the performance by the Company or the Guarantors of their obligations under this Agreement, the Securities and the Guarantees, respectively (a “Material Adverse Effect”). The Company does not own
an interest in or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries and the Joint Ventures listed on Schedule 3 of this Agreement and a less than 5% interest in Azure Midstream Holdings, LLC.

 (i) Capitalization. The Company has the authorized capitalization as set forth in each of the Registration Statement, the Time of
Sale Information and the Prospectus under the heading “Capitalization” and all the outstanding shares of capital stock or other equity interests of each subsidiary of the Company and the Company’s interest in the Joint Ventures have
been duly and validly authorized and issued, are fully paid and non-assessable and are owned directly or indirectly by the Company, free and clear of any 

  
 7 








 
lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party, except pursuant to the Credit Agreement and the organizational and
governance documents of each of the Joint Ventures listed on Schedule 3 of this Agreement. 
 (j) Due Authorization. Each of the
Company and the Guarantors has full right, power and authority to execute and deliver this Agreement, the Securities and the Indenture (including the Guarantees set forth therein) (collectively, the “Transaction Documents”), to the extent
it is a party thereto and to perform its respective obligations hereunder and thereunder; and all action required to be taken for the due and proper authorization, execution and delivery of each of the Transaction Documents to which it is a party
and the consummation by each of them of the transactions contemplated thereby has been duly and validly taken. 
 (k) The Indenture.
The Base Indenture has been duly authorized, executed and delivered by the Company and each of the Guarantors and has been duly qualified under the Trust Indenture Act and constitutes a valid and legally binding agreement of the Company and each
of the Guarantors enforceable against the Company and each of the Guarantors in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer or similar laws
affecting the enforcement of creditors’ rights generally or by equitable principles relating to enforceability (collectively, the “Enforceability Exceptions”). The Third Supplemental Indenture has been duly authorized by the Company
and each of the Guarantors and, when duly executed and delivered in accordance with its terms by each of the parties thereto, the Indenture will constitute a valid and legally binding agreement of the Company and each of the Guarantors enforceable
against the Company and each of the Guarantors in accordance with its terms, except as enforceability may be limited by the Enforceability Exceptions. 

(l) The Securities and the Guarantees. The Securities have been duly authorized by the Company and, when duly executed, authenticated,
issued and delivered as provided in the Indenture and paid for as provided herein, will constitute valid and legally binding obligations of the Company enforceable against the Company in accordance with their terms, subject to the Enforceability
Exceptions, and will be entitled to the benefits of the Indenture; and the Guarantees have been duly authorized by each of the Guarantors and, when the Securities have been duly executed, authenticated, issued and delivered as provided in the
Indenture and paid for as provided herein, will be valid and legally binding obligations of each of the Guarantors, enforceable against each of the Guarantors in accordance with their terms, except that the enforceability is subject to the
Enforceability Exceptions, and will be entitled to the benefits of the Indenture. 
 (m) Underwriting Agreement. This Agreement has
been duly authorized, executed and delivered by the Company and each of the Guarantors. 

  
 8 








 (n) Descriptions of the Transaction Documents. Each Transaction Document conforms in all
material respects to the description thereof contained in each of the Registration Statement, the Time of Sale Information and the Prospectus. 

(o) No Violation or Default. Neither the Company nor any of its subsidiaries is (i) in violation of its charter or by-laws or
similar organizational documents, (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of
the Company or any of its subsidiaries is subject, or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses
(ii) and (iii) above, for any such default or violation that would not, individually or in the aggregate, have a Material Adverse Effect. 

(p) No Conflicts. The execution, delivery and performance by the Company and each of the Guarantors of each of the Transaction Documents
to which it is a party, the issuance and sale of the Securities (including the Guarantees) and compliance by the Company and each of the Guarantors with the terms thereof and the consummation of the transactions contemplated by the Transaction
Documents will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, result in the termination, modification or acceleration of, or result in the creation or imposition of
any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, (ii) result in any violation of the provisions of the charter or
by-laws or similar organizational documents of the Company or any of its subsidiaries, or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory
authority, except, in the case of clauses (i) and (iii) above, for any such conflict, breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, have a Material Adverse Effect. 

(q) No Consents Required. No approval, authorization, consent or order of or filing with any federal, state, local or foreign
governmental or regulatory commission, board, body, authority or agency, or of or with the rules of the New York Stock Exchange, or approval of the shareholders of the Company or its subsidiaries, is required in connection with the execution,
delivery and performance by the Company and each of the Guarantors of each of the Transaction Documents to which it is a party, the issuance and sale by the Company of the Securities and the issuance by the Guarantors of the Guarantees or the
consummation of the transactions as contemplated hereby and by the Transaction Documents, except for the registration of the Securities and the Guarantees under the Securities Act, the qualification of the


  
 9 








 
Indenture under the Trust Indenture Act and such consents, approvals, authorizations, orders and registrations or qualifications as may be required under applicable state securities laws in
connection with the purchase, offer and distribution of the Securities by the Underwriters. 
 (r) Legal Proceedings. Except as
described in each of the Registration Statement, the Time of Sale Information and the Prospectus, there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings
(“Actions”) pending to which the Company or any of its subsidiaries is or may be a party or to which any property of the Company or any of its subsidiaries is or may be the subject that, individually or in the aggregate, if determined
adversely to the Company or any of its subsidiaries, could reasonably be expected to have a Material Adverse Effect; no Actions are, to the knowledge of the Company and each of the Guarantors, threatened or contemplated by any governmental or
regulatory authority or other parties; and (i) there are no current or pending Actions that are required under the Securities Act to be described in the Registration Statement or the Prospectus that are not so described in the Registration
Statement, the Time of Sale Information and the Prospectus and (ii) there are no statutes, regulations or contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described
in the Registration Statement or the Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement, the Time of Sale Information and the Prospectus. 

(s) Independent Accountants. KPMG, LLP, who has certified certain financial statements of the Company and its subsidiaries, was at the
time of such certification an independent registered public accounting firm with respect to the Company and its subsidiaries, as required by the Securities Act and the Exchange Act, and the applicable published rules and regulations thereunder and
the rules and regulations of the Public Company Accounting Oversight Board. KPMG, LLP, who has certified certain financial statements of the Acquired Chesapeake Properties and TGGT, was at the applicable time of such certification an independent
auditor with respect to the Acquired Chesapeake Properties and TGGT within the applicable rules and regulations adopted by the American Institute of Certified Public Accountants. 

(t) Title to Real and Personal Property. The Company and each of its subsidiaries have good and marketable title to all material
property (real and personal), or has valid rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Company and its subsidiaries described or incorporated by reference in the
Registration Statement, the Time of Sale Information and the Prospectus as being owned by each of them, free and clear of all liens, claims, security interests or other encumbrances except those that (i) do not materially interfere with the use
made and proposed to be made of such property by the Company and its subsidiaries, (ii) could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect or (iii) were placed on such property in
connection with the Credit Agreement and the organizational documents of the Joint Ventures. 

  
 10 








 (u) Title to Intellectual Property. The Company and its subsidiaries own or possess
adequate rights to use all material patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses and know-how (including trade secrets and other unpatented and/or
unpatentable proprietary or confidential information, systems or procedures) necessary for the conduct of their respective businesses; and the conduct of their respective businesses will not conflict in any material respect with any such rights of
others, and the Company and its subsidiaries have not received any notice of any claim of infringement or conflict with any such rights of others. 

(v) Investment Company Act. Neither the Company nor any of its subsidiaries is and, after giving effect to the offering and sale of the
Securities and the application of the proceeds thereof as described in the Registration Statement, the Time of Sale Information and the Prospectus, none of them will be an “investment company” or an entity “controlled” by an
“investment company” within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Investment Company Act”). 

(w) Taxes. The Company and its subsidiaries have paid all federal, state, local and foreign taxes and filed all tax returns required to
be paid or filed through the date hereof, except for any failure to pay such taxes or file such returns that would not, individually or in the aggregate, have a Material Adverse Effect; and except as otherwise disclosed in each of the Registration
Statement, the Time of Sale Information and the Prospectus, there is no material tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or
assets. 
 (x) Licenses and Permits. The Company and its subsidiaries possess all licenses, sub-licenses, certificates, permits and
other authorizations issued by, and have made all filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of
their respective businesses as described in each of the Registration Statement, the Time of Sale Information and the Prospectus, except where the failure to possess or make the same would not, individually or in the aggregate, have a Material
Adverse Effect; and except as described in each of the Registration Statement, the Time of Sale Information and the Prospectus, neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such
license, sub-license, certificate, permit or authorization, except for any revocation or modification or failure to renew that would not, individually or in the aggregate, have a Material Adverse Effect. 

(y) No Labor Disputes. Neither the Company nor its subsidiaries are involved in any labor dispute with their respective employees nor,
to the knowledge of the Company, is any such dispute threatened except, in each case, for disputes which would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

  
 11 








 (z) Compliance With Environmental Laws. (i) The Company and its subsidiaries
(x) are in compliance with any and all applicable federal, state, local and foreign laws, rules, regulations, requirements, decisions and orders relating to the protection of human health or safety, the environment, natural resources, hazardous
or toxic substances or wastes, pollutants or contaminants (collectively, “Environmental Laws”); (y) have received and are in compliance with all permits, licenses, certificates or other authorizations or approvals required of them
under applicable Environmental Laws to conduct their respective businesses; and (z) have not received notice of any actual or potential liability under or relating to any Environmental Laws, including for the investigation or remediation of any
disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice; and (ii) there are no costs or
liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i) and (ii) above, for any such failure to comply, or failure to receive required permits, licenses,
certificates or other authorizations, or approvals, or cost or liability, as would not, individually or in the aggregate, have a Material Adverse Effect; and (iii) except as described in each of the Time of Sale Information and the Prospectus,
(x) there are no proceedings that are pending, or that are known to be contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceedings
regarding which it is reasonably believed no monetary sanctions of $100,000 or more will be imposed, and (y) the Company and its subsidiaries are not aware of any issues regarding compliance with Environmental Laws, or liabilities or other
obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that could reasonably be expected to have a material adverse effect on the capital expenditures, earnings or competitive position
of the Company and its subsidiaries, and (z) none of the Company and its subsidiaries anticipates material capital expenditures relating to any Environmental Laws. 

(aa) Compliance with ERISA. (i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement
Income Security Act of 1974, as amended (“ERISA”), for which the Company or any member of its “Controlled Group” (defined as any organization which is a member of a controlled group of companies within the meaning of
Section 414 of the Internal Revenue Code of 1986, as amended (the “Code”)) has or could have any liability (each, a “Plan”) has been maintained in compliance, in all material respects, with its terms and the requirements of
any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect
to any Plan, excluding transactions effected pursuant to a statutory, administrative or other applicable exemption (including individual exemptions that have been or will be applied for with the U.S. Department of Labor); (iii) no Plan that is
subject to the funding rules of Sections 

  
 12 








 
412 or 430 of the Code or Section 302 of ERISA has failed to satisfy the minimum funding standards applicable to such Plan, whether or not waived, and no such Plan has been determined to be,
or is reasonably expected to be, in “at risk” status (within the meaning of Section 430 of the Code or Section 303 of ERISA); (iv) the fair market value of the assets of each Plan equals or exceeds the present value of all
benefits accrued under such Plan (determined based on those assumptions used to fund such Plan); (v) no “reportable event” (within the meaning of Section 4043(c) of ERISA) has occurred or is reasonably expected to occur;
(vi) each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified and to the knowledge of the Company and the Guarantors, nothing has occurred, whether by action or by failure to act, which would cause the
loss of such qualification; and (vii) neither the Company nor any member of its Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the
Pension Benefit Guarantee Corporation, in the ordinary course and without default) in respect of a Plan (including a “multiemployer plan,” within the meaning of Section 4001(a)(3) of ERISA). 

(bb) Disclosure Controls. The Company maintains an effective system of “disclosure controls and procedures” (as defined in
Rule 13a-15(e) of the Exchange Act) that is designed to ensure that material information required to be disclosed by the Company, including its consolidated subsidiaries, in reports that it files or submits under the Exchange Act is recorded,
processed, summarized and reported as required under the Exchange Act within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and
communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure. The Company has carried out evaluations of the effectiveness of its disclosure controls and procedures as required by Rule 13a-15
of the Exchange Act. 
 (cc) Accounting Controls. The Company and its subsidiaries maintain systems of “internal control over
financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial
officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles, including, but not limited to internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability; (iii) access to assets is permitted only in accordance with
management’s general or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and
(v) interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Prospectus and the Time of Sale Information is prepared in accordance with the


  
 13 








 
Commission’s rules and guidelines applicable thereto. Except as disclosed in each of the Registration Statement, the Time of Sale Information and the Prospectus, there are no material
weaknesses or significant deficiencies in the Company’s internal controls. 
 (dd) Insurance. The Company and its subsidiaries
have insurance covering their respective properties, operations, personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and risks as are adequate to protect the Company and
its subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries has (i) received notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to
be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers
as may be necessary to continue its business. 
 (ee) No Unlawful Payments. None of the Company, any of its subsidiaries or, to the
knowledge of the Company and each of the Guarantors, any director, officer, or employee of the Company or any of its subsidiaries, or any agent, or other person associated with or acting on behalf of the Company or any of its subsidiaries has
(i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or
indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on
behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or
regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom, or any other applicable anti-bribery or
anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or
improper payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws. 

(ff) Compliance with Money Laundering Laws. The operations of the Company and its subsidiaries are and, to the knowledge of the Company,
have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes
of all jurisdictions where the Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency
(collectively, the “Anti-Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the
Anti-Money Laundering Laws is pending or, to the knowledge of the Company or any of the Guarantors, threatened. 

  
 14 








 (gg) No Conflicts with Sanctions Laws. None of the Company, any of its subsidiaries, or,
to the knowledge of the Company and the Guarantors, any director, officer, employee, agent or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions
administered or enforced by the U.S. government (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”) or the U.S. Department of State and including, without limitation, the
designation as a “specially designated national” or “blocked person”), the United Nations Security Council (“UNSC”), the European Union, Her Majesty’s Treasury (“HMT”), or other relevant sanctions
authority (collectively, “Sanctions”), nor is the Company, any of its subsidiaries or any of the Guarantors located, organized or resident in a country or territory that is the subject or the target of Sanctions, including, without
limitation, Cuba, Iran, North Korea, Sudan and Syria (each, a “Sanctioned Country”); and the Company will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make
available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person, that, at the time of such funding or facilitation, is the subject or the target
of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as
underwriter, advisor, investor or otherwise) of Sanctions. For the past five years, the Company and its subsidiaries have not knowingly engaged in, and are not now knowingly engaged in, any dealings or transactions with any person that at the time
of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country. 
 (hh) Solvency. On
and immediately after the Closing Date, none of the Company nor any of the Guarantors (after giving effect to the issuance of the Securities (including the Guarantees) and the other transactions related thereto as described in the Registration
Statement, the Time of Sale Information and the Prospectus) will be “insolvent” as defined under the United States Bankruptcy Code. 

(ii) No Restrictions on Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement
or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiary’s capital stock or similar ownership interest, from repaying to the Company any loans or
advances to such subsidiary from the Company or from transferring any of such subsidiary’s properties or assets to the Company or any other subsidiary of the Company. 

(jj) No Broker’s Fees. Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with
any person (other than this Agreement) that would give rise to a valid claim against the Company or any of its subsidiaries or any Underwriter for a brokerage commission, finder’s fee or like payment in connection with the offering and sale of
the Securities. 

  
 15 








 (kk) No Registration Rights. No person has the right to require the Company or any of its
subsidiaries to register any Securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Securities. 

(ll) No Stabilization. Neither the Company nor any of the Guarantors has taken, directly or indirectly, any action designed to or that
could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. 
 (mm)
Sarbanes-Oxley Act. There is and has been no failure on the part of the Company or any of the Company’s directors or officers, in their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act
of 2002, as amended, and the rules and regulations promulgated in connection therewith (the “Sarbanes-Oxley Act”), including Section 402 related to loans and Sections 302 and 906 related to certifications. 

(nn) Status under the Securities Act. The Company is not an ineligible issuer and is a well-known seasoned issuer, in each case as
defined under the Securities Act, in each case at the times specified in the Securities Act in connection with the offering of the Securities. 

(oo) Reserve Report Data. Other than as disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, the
oil and gas reserve estimates of the Company and its subsidiaries for the fiscal years ended December 31, 2013, 2012 and 2011 contained in the Registration Statement, the Time of Sale Information and the Prospectus are derived from reports that
have been prepared by or have been audited by either (a) Lee Keeling and Associates, Inc. (b) Haas Petroleum Engineering Services Inc., (c) Ryder Scott Company, L.P., (d) Netherland, Sewell & Associates, Inc. or
(e) the Company’s internal engineers, as set forth therein, and such reserves were prepared in accordance with the Statement of Financial Accounting Standards No. 69 and Rule 4-10 of Regulation S-X. 

(pp) Independent Reserve Engineering Firm. Each of Lee Keeling and Associates, Inc., Haas Petroleum Engineering Services Inc., Ryder
Scott Company, L.P. and Netherland, Sewell & Associates, Inc., who have certified the oil and gas reserve estimates of the Company and its subsidiaries, has represented to the Company that it is, and the Company believes each to be, an
independent reserve engineering firm with respect to the Company and its subsidiaries for the periods set forth in the Registration Statement, the Time of Sale Information and the Prospectus. 

(qq) Federal Power Act. None of the Company or any of its subsidiaries is subject to regulation as a “public utility company”,
“public service company”, “holding company” (or similar designation) by any governmental or regulatory authority, including under the Federal Power Act, as amended (“FPA”) or any applicable state utility laws. 

  
 16 








 4. Further Agreements of the Company and the Guarantors. The Company and each of the
Guarantors jointly and severally covenant and agree with each Underwriter that: 
 (a) Required Filings. The Company will file the
final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act, will file any Issuer Free Writing Prospectus (including the Term Sheet in the form of Annex C hereto) to the
extent required by Rule 433 under the Securities Act; and will file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of
the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Securities; and the Company will furnish copies of the Prospectus and each Issuer
Free Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement in such quantities as the Representative
may reasonably request. The Company will pay the registration fees for this offering within the time period required by Rule 456(b)(1)(i) under the Securities Act (without giving effect to the proviso therein) and in any event prior to the Closing
Date. 
 (b) Delivery of Copies. The Company will deliver, without charge, (i) to the Representative, two copies of the signed
Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and documents incorporated by reference therein, and (ii) make available to each Underwriter electronically
through EDGAR (A) a conformed copy of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and (B) deliver, without charge, during the Prospectus
Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein) and each Issuer Free Writing Prospectus as the Representative may reasonably
request. As used herein, the term “Prospectus Delivery Period” means such period of time after the first date of the public offering of the Securities as in the opinion of counsel for the Underwriters a prospectus relating to the
Securities is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Securities by any Underwriter or dealer. 

(c) Amendments or Supplements; Issuer Free Writing Prospectuses. Prior to the later of (i) the Closing Date or (ii) the
expiration of the Prospectus Delivery Period, before preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement or the Prospectus,
whether before or after the time that the Registration Statement becomes effective the Company will furnish to the Representative and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus,


  
 17 








 
amendment or supplement for review and will not prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to
which the Representative reasonably objects. 
 (d) Notice to the Representative. The Company will advise the Representative promptly,
and confirm such advice in writing, (i) when any amendment to the Registration Statement filed prior to the later of (x) the Closing Date or (y) the expiration of the Prospectus Delivery Period or otherwise relating to the Securities
has been filed or becomes effective; (ii) when any supplement to the Prospectus or any amendment to the Prospectus or any Issuer Free Writing Prospectus relating to the Securities has been filed; (iii) of any request by the Commission for
any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional
information as of the later of (x) the Closing Date or (y) the expiration of the Prospectus Delivery Period; (iv) of the issuance by the Commission of any order suspending the effectiveness of the Registration Statement or preventing
or suspending the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; (v) of the occurrence of any event within the
Prospectus Delivery Period as a result of which the Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Time of Sale Information or any such Issuer Free Writing Prospectus is delivered to a purchaser,
not misleading; (vi) of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act; and
(vii) of the receipt by the Company of any notice with respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company
will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending any such
qualification of the Securities and, if any such order is issued, will use its reasonable best efforts to obtain as soon as possible the withdrawal thereof. 

(e) Time of Sale Information. If at any time prior to the Closing Date (i) any event shall occur or condition shall exist as a
result of which any of the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading or (ii) it is necessary to amend or supplement the Time of Sale Information to comply with applicable law, the Company will promptly notify the Underwriters thereof and forthwith prepare
and, subject to paragraph (c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the 

  
 18 








 
Representative may designate, such amendments or supplements to the Time of Sale Information (or any document to be filed with the Commission and incorporated by reference therein) as may be
necessary so that the statements in any of the Time of Sale Information as so amended or supplemented (including such documents to be incorporated by reference therein) will not, in the light of the circumstances under which they were made, be
misleading or so that any of the Time of Sale Information will comply with applicable law. 
 (f) Ongoing Compliance. If during the
Prospectus Delivery Period (i) any event shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus
to comply with applicable law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission and furnish to the Underwriters and to such dealers as the
Representative may designate, such amendments or supplements to the Prospectus (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Prospectus as so amended or
supplemented including such documents to be incorporated by reference therein will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with applicable
law. 
 (g) Blue Sky Compliance. The Company will qualify the Securities for offer and sale under the securities or Blue Sky laws of
such jurisdictions as the Representative shall reasonably request and will continue such qualifications in effect so long as required for distribution of the Securities; provided that the Company shall not be required to (i) qualify as a
foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to service of process in any such jurisdiction or (iii) subject
itself to taxation in any such jurisdiction if it is not otherwise so subject. 
 (h) Earning Statement. The Company will make
generally available to its security holders and the Representative as soon as practicable an earning statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a
period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the “effective date” (as defined in Rule 158) of the Registration Statement. 

(i) Clear Market. During the period from the date hereof through and including the date that is 90 days after the date hereof, the
Company will not, without the prior written consent of the Representative, offer, sell, contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Company and having a tenor of more than one year. 

  
 19 








 (j) Use of Proceeds. The Company will apply the net proceeds from the sale of the
Securities as described in each of the Registration Statement, the Time of Sale Information and the Prospectus under the heading “Use of proceeds”. 

(k) No Stabilization. The Company will not take, directly or indirectly, any action designed to or that could reasonably be expected to
cause or result in any stabilization or manipulation of the price of the Securities. 
 (l) Record Retention. The Company will,
pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. 

5. Certain Agreements of the Underwriters. Each Underwriter hereby represents and agrees that 

(a) It has not and will not use, authorize use of, refer to, or participate in the planning for use of, any “free writing
prospectus”, as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and any press release
issued by the Company) other than (i) a free writing prospectus that, solely as a result of use by such Underwriter, would not trigger an obligation to file such free writing prospectus with the Commission pursuant to Rule 433, (ii) any
Issuer Free Writing Prospectus listed on Annex B or prepared pursuant to Section 3(c) or Section 4(c) above (including any electronic road show); or (iii) any free writing prospectus prepared by such Underwriter and approved by the
Company in advance in writing (each such free writing prospectus referred to in clauses (i) or (iii), an “Underwriter Free Writing Prospectus”). Notwithstanding the foregoing, the Underwriters may use a term sheet substantially in the
form of Annex C hereto without the consent of the Company. 
 (b) It is not subject to any pending proceeding under Section 8A of the
Securities Act with respect to the offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). 

6. Conditions of Underwriters’ Obligations. The obligation of each Underwriter to purchase Securities on the Closing Date as
provided herein is subject to the performance by the Company and each of the Guarantors of their respective covenants and other obligations hereunder and to the following additional conditions: 

(a) Registration Compliance; No Stop Order. No order suspending the effectiveness of the Registration Statement shall be in effect, and
no proceeding for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or threatened by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely
filed with the Commission under the Securities Act (in the case of an Issuer Free Writing 

  
 20 








 
Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section 4(a) hereof; and all requests by the Commission for additional information shall have
been complied with to the reasonable satisfaction of the Representative. 
 (b) Representations and Warranties. The representations
and warranties of the Company and each of the Guarantors contained herein shall be true and correct on the date hereof and on and as of the Closing Date; and the statements of the Company and each of the Guarantors, and their respective officers
made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date. 
 (c) No
Downgrade. Between the earlier of (A) the Time of Sale and (B) the execution and delivery of this Agreement and the Closing Date, (i) no downgrading shall have occurred in the rating accorded the Securities or any other debt
securities or preferred stock of or guaranteed by the Company or any of the Guarantors by any “nationally recognized statistical rating organization”, as such term is defined under Section 3(a)(62) of the Exchange Act and (ii) no
such organization shall have publicly announced that it has under surveillance or review, or has changed its outlook with respect to, its rating of the Securities or of any other debt securities or preferred stock of or guaranteed by the Company or
any of its subsidiaries (other than an announcement with positive implications of a possible upgrading). 
 (d) No Material Adverse
Change. No event or condition of a type described in Section 3(g) hereof shall have occurred or become known between the time of execution of this Agreement and the Closing Date, which event or condition is not described in each of the
Registration Statement, the Time of Sale Information (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the Representative is so material and
adverse as to make it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Registration Statement, the Time of Sale Information and the
Prospectus. 
 (e) Officer’s Certificate. The Representative shall have received on and as of the Closing Date a certificate of
an executive officer of the Company and each Guarantor who has specific knowledge of the Company’s or such Guarantor’s financial matters and is satisfactory to the Representative (i) confirming that such officer has carefully reviewed
the Registration Statement, the Time of Sale Information and the Prospectus and, to the knowledge of such officer, the representations set forth in Sections 3(b) and 3(d) hereof are true and correct as of the Closing Date, (ii) confirming that
the other representations and warranties of the Company and the Guarantors in this Agreement are true and correct as of the Closing Date and that the Company and the Guarantors have complied with all agreements and satisfied all conditions on their
part to be performed or satisfied hereunder at or prior to the Closing Date and (iii) to the effect set forth in paragraphs (a), (c) and (d) above. 

  
 21 








 (f) Comfort Letters. On the date of this Agreement and on the Closing Date, KPMG, LLP
shall have furnished to the Representative, at the request of the Company, letters with respect to each of the Company and its subsidiaries, the Acquired Chesapeake Properties and TGGT, dated the respective dates of delivery thereof and addressed to
the Underwriters, in form and substance reasonably satisfactory to the Representative, containing statements and information of the type customarily included in accountants’ “comfort letters” to underwriters with respect to the
financial statements and certain financial information contained or incorporated by reference in each of the Registration Statement, the Time of Sale Information and the Prospectus; provided that the letter delivered on the Closing Date shall
use a “cut-off” date no more than three business days prior to the Closing Date. 
 (g) Opinion and 10b-5 Statement of Counsel
for the Company. (i) Haynes and Boone LLP, counsel for the Company, shall have furnished to the Representative, at the request of the Company, their written opinion and 10b-5 Statement, dated the Closing Date and addressed to the
Underwriters, in form and substance reasonably satisfactory to the Representative, substantially to the effect set forth in Annex D hereto and (ii) William L. Boeing, general counsel for the Company, shall have furnished to the Representative,
at the request of the Company, his written opinion, dated the Closing Date and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative, substantially to the effect set forth in Annex E hereto. 

(h) Opinion and 10b-5 Statement of Counsel for the Underwriters. The Representative shall have received on and as of the Closing Date an
opinion and 10b-5 Statement of Simpson Thacher & Bartlett LLP, counsel for the Underwriters, with respect to such matters as the Representative may reasonably request, and such counsel shall have received such documents and information as
they may reasonably request to enable them to pass upon such matters. 
 (i) No Legal Impediment to Issuance. No action shall have
been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities
or the issuance of the Guarantees; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities or the issuance of the Guarantees. 

(j) Good Standing. The Representative shall have received on and as of the Closing Date satisfactory evidence of the good standing of
the Company and the Guarantors in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Representative may reasonably request, in each case in writing or any standard form of telecommunication from
the appropriate governmental authorities of such jurisdictions. 

  
 22 








 (k) Reserve Report Confirmation Letters. On the date of this Agreement and on the Closing
Date, Lee Keeling and Associates, Inc., Haas Petroleum Engineering Services Inc., Ryder Scott Company, L.P. and Netherland, Sewell & Associates, Inc., each shall have furnished to the Representative, at the request of the Company, letters,
dated the respective dates of delivery thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative, containing statements and information with respect to the estimated oil and gas reserves of the
Company and its subsidiaries contained in the Registration Statement, the Time of Sale Information and the Prospectus. 
 (l) Chief
Financial Officer Certificate. The Representative shall have received on and as of the Closing Date a certificate of the chief financial officer of the Company confirming that (i) he is familiar with the books and records and internal
accounting practices, policies, procedures and controls of the Company and has had responsibility for accounting matters with respect to the Company, (ii) he has reviewed the identified information, which is included in the Registration
Statement, the Time of Sale Information and the Prospectus and which has not been otherwise reviewed by KPMG, LLP, the Company’s independent registered public accounting firm, and (iii) attesting to the accuracy of the identified
information in all material respects. 
 (m) New Borrowing Base Notice. On or prior to the Closing Date, the Company shall have
received the New Borrowing Base Notice (as defined in the Credit Agreement) setting forth the redetermined Borrowing Base (as defined in the Credit Agreement) in an amount of no less than $1.0 billion (such amount to be further and automatically
reduced on the Closing Date by $125.0 million as a result of the issuance of the Securities). 
 (n) DTC. The Securities shall be
eligible for clearance and settlement through DTC. 
 (o) Third Supplemental Indenture and Securities. The Third Supplemental
Indenture shall have been duly executed and delivered by a duly authorized officer of the Company, each of the Guarantors and the Trustee, and the Securities shall have been duly executed and delivered by a duly authorized officer of the Company and
duly authenticated by the Trustee. 
 (p) Additional Documents. On or prior to the Closing Date, the Company and the Guarantors shall
have furnished to the Representative such further certificates and documents as the Representative may reasonably request. 
 All opinions,
letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. 

  
 23 








 7. Indemnification and Contribution. 

(a) Indemnification of the Underwriters. The Company and each of the Guarantors jointly and severally agree to indemnify and hold
harmless each Underwriter, its affiliates, directors and officers and each person, if any, who controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all
losses, claims, damages and liabilities (including, without limitation, reasonable legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or
several, that arise out of, or are based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact
required to be stated therein or necessary in order to make the statements therein, not misleading, (ii) or any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement
thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use therein, it being understood and agreed that the only such information furnished by any
Underwriter consists of the information described as such in subsection (b) below. 
 The Company and each of the Guarantors also
jointly and severally agree to indemnify and hold harmless Capital One Securities, Inc., its affiliates, directors and officers and each person, if any, who controls Capital One Securities, Inc. within the meaning of Section 15 of the Securities Act
or Section 20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities incurred as a result of Capital One Securities, Inc.’s participation as a “qualified independent underwriter” within the meaning
of Rule 5121 of FINRA in connection with the offering of the Securities. 
 (b) Indemnification of the Company and the
Guarantors. Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, each of the Guarantors, and each of their respective directors, their respective officers who signed the Registration Statement and each
person, if any, who controls the Company or any of the Guarantors within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only
with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such
Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus or any Time
of Sale Information, it being understood and agreed that the only such information furnished by any Underwriter consists of the following: the second and third sentences concerning discounts and commissions under the third paragraph, the third
sentence certain market making activities of the ninth paragraph, and the tenth paragraph concerning certain stabilization transactions under the heading “Underwriting”. 

  
 24 








 (c) Notice and Procedures. If any suit, action, proceeding (including any governmental or
regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a) or (b) above, such person (the “Indemnified Person”)
shall promptly notify the person against whom such indemnification may be sought (the “Indemnifying Person”) in writing; provided that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may
have under paragraph (a) or (b) of this Section 7 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided, further, that the
failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under paragraph (a) or (b) of this Section 7. If any such proceeding shall be brought or
asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified
Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to Section 7 that the Indemnifying Person may designate in such proceeding and shall pay the fees and
expenses of such proceeding and shall pay the fees and expenses of counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such
counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain
counsel reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the
Indemnifying Person; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be
inappropriate due to actual or potential differing interest between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees
and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be reimbursed as they are incurred, provided, however that if indemnity may be sought
pursuant to the second paragraph of Section 7(a) above in respect of such proceeding, then in addition to such separate firm of the Underwriters, their affiliates and such control persons of the Underwriters, the indemnifying party shall be liable
for the fees and expenses of not more than one separate firm (in addition to any local counsel) for Capital One Securities, Inc. in its capacity as a “qualified independent underwriter,” its affiliates, directors, officers and all persons,
if any, who control Capital One Securities, Inc. within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control
persons of such Underwriter shall be designated in writing by J.P. Morgan Securities LLC and any such separate firm for the Company, the Guarantors, their respective directors, their respective officers who signed the Registration Statement and any
control persons of the Company shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a
final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an
Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding
effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have reimbursed the Indemnified Person in
accordance 

  
 25 








 
with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened
proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such
Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault,
culpability or a failure to act by or on behalf of any Indemnified Person. 
 (d) Contribution. If the indemnification provided for in
paragraphs (a) and (b) above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying
such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits
received by the Company and the Guarantors on the one hand and the Underwriters or Capital One Securities, Inc. in its capacity as a “qualified independent underwriter”, as the case may be, on the other from the offering of the Securities
or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company
and the Guarantors on the one hand and the Underwriters or Capital One Securities, Inc. in its capacity as a “qualified independent underwriter”, as the case may be, on the other in connection with the statements or omissions that resulted
in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Guarantors on the one hand and the Underwriters or Capital One Securities, Inc. in its
capacity as a “qualified independent underwriter”, as the case may be, on the other shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the
Securities and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the cover of the Prospectus, or the fee to be received by Capital One Securities, Inc. in
its capacity as a “qualified independent underwriter”, as the case may be, bear to the aggregate offering price of the Securities. The relative fault of the Company and the Guarantors on the one hand and the Underwriters or Capital One
Securities, Inc. in its capacity as a “qualified independent underwriter”, as the case may be, on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information supplied by the Company or any Guarantor or by the Underwriters or Capital One Securities, Inc. in its capacity as a “qualified independent underwriter”, as the
case may be, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 

(e) Limitation on Liability. The Company, the Guarantors and the Underwriters agree that it would not be just and equitable if
contribution pursuant to this Section 7 were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable
considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the
limitations set forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the 

  
 26 








 
provisions of this Section 7, in no event shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received
by such Underwriter with respect to the offering of the Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No
person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters’
obligations to contribute pursuant to this Section 7 are several in proportion to their respective purchase obligations hereunder and not joint. 

(f) Non-Exclusive Remedies. The remedies provided for in this Section 7 are not exclusive and shall not limit any rights or
remedies that may otherwise be available to any Indemnified Person at law or in equity. 
 8. Effectiveness of Agreement. This
Agreement shall become effective upon the execution and delivery hereof by the parties hereto. 
 9. Termination. This Agreement may
be terminated in the absolute discretion of the Representative, by notice to the Company, if after the execution and delivery of this Agreement and on or prior to the Closing Date (i) trading of securities generally shall have been suspended or
materially limited on the New York Stock Exchange or the over-the-counter market; (ii) trading of any securities issued or guaranteed by the Company or any of the Guarantors shall have been suspended on any exchange or in any over-the-counter
market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial
markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the
Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Prospectus. 
 10.
Defaulting Underwriter. (a) If, on the Closing Date, any Underwriter defaults on its obligation to purchase the Securities that it has agreed to purchase hereunder, the non-defaulting Underwriters may in their discretion arrange for the
purchase of such Securities by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such
Securities, then the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase such Securities on such terms. If other persons become obligated or
agree to purchase the Securities of a defaulting Underwriter, either the non-defaulting Underwriters or the Company may postpone the Closing Date for up to five full business days in order to effect any
changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement, the Time of Sale 

  
 27 








 
Information and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Registration Statement, the Time of Sale
Information and the Prospectus that effects any such changes. As used in this Agreement, the term “Underwriter” includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto
that, pursuant to this Section 10, purchases Securities that a defaulting Underwriter agreed but failed to purchase. 
 (b) If, after
giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph (a) above, the aggregate principal amount of such
Securities that remains unpurchased does not exceed one-eleventh of the aggregate principal amount of all the Securities, then the Company shall have the right to require each non-defaulting Underwriter to purchase the principal amount of Securities
that such Underwriter agreed to purchase hereunder plus such Underwriter’s pro rata share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder) of the Securities of such defaulting
Underwriter or Underwriters for which such arrangements have not been made. 
 (c) If, after giving effect to any arrangements for the
purchase of the Securities of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph (a) above, the aggregate principal amount of such Securities that remains unpurchased exceeds
one-eleventh of the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in paragraph (b) above, then this Agreement shall terminate without liability on the part of the non-defaulting
Underwriters. Any termination of this Agreement pursuant to this Section 10 shall be without liability on the part of the Company, except that the Company will continue to be liable for the payment of expenses as set forth in Section 11
hereof and except that the provisions of Section 7 hereof shall not terminate and shall remain in effect. 
 (d) Nothing contained
herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter for damages caused by its default. 

11. Payment of Expenses. (a) Whether or not the transactions contemplated by this Agreement are consummated or this
Agreement is terminated, the Company and each of the Guarantors jointly and severally agree to pay or cause to be paid all costs and expenses incident to the performance of their respective obligations hereunder, including without limitation,
(i) the costs incident to the authorization, issuance, sale, preparation and delivery of the Securities and any taxes payable in that connection; (ii) the costs incident to the preparation, printing and filing under the Securities Act of
the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Time of Sale Information and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii) the
costs of reproducing and distributing each of the Transaction Documents; (iv) the fees 

  
 28 








 
and expenses of the Company’s and the Guarantors’ counsel and independent accountants; (v) the fees and expenses incurred in connection with the registration or qualification and
determination of eligibility for investment of the Securities under the laws of such jurisdictions as the Representative may designate and the preparation, printing and distribution of a Blue Sky Memorandum (including the related fees and expenses
of counsel for the Underwriters); (vi) any fees charged by rating agencies for rating the Securities; (vii) the fees and expenses of the Trustee and any paying agent (including related fees and expenses of any counsel to such parties);
(viii) all expenses and application fees incurred in connection with any filing with, and clearance of the offering by, the Financial Industry Regulatory Authority, Inc.; and (ix) all expenses incurred by the Company in connection with any
“road show” presentation to potential investors. 
 (b) If (i) this Agreement is terminated pursuant to Section 9,
(ii) the Company for any reason fails to tender the Securities for delivery to the Underwriters or (iii) the Underwriters decline to purchase the Securities for any reason permitted under this Agreement, the Company and each of the
Guarantors jointly and severally agree to reimburse the Underwriters for all out-of-pocket costs and expenses (including the reasonable fees and expenses of their counsel) reasonably incurred by the Underwriters in connection with this Agreement and
the offering contemplated hereby. 
 12. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be
binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Underwriter referred to in Section 7 hereof. Nothing in this Agreement is
intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Securities from any Underwriter shall be deemed to be a
successor merely by reason of such purchase. 
 13. Survival. The respective indemnities, rights of contribution, representations,
warranties and agreements of the Company, the Guarantors and the Underwriters contained in this Agreement or made by or on behalf of the Company, the Guarantors or the Underwriters pursuant to this Agreement or any certificate delivered pursuant
hereto shall survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters. 

14. Certain Defined Terms. For purposes of this Agreement, (a) except where otherwise expressly provided, the term
“affiliate” has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day other than a day on which banks are permitted or required to be closed in New York City; and (c) the
term “subsidiary” has the meaning set forth in Rule 405 under the Securities Act. For the avoidance of doubt, the term “subsidiary” shall exclude the Joint Ventures. 

  
 29 








 15. Compliance with USA Patriot Act. In accordance with the requirements of the USA
Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include
the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. 

16. Miscellaneous. (a) Authority of the Representative. Any action by the Underwriters hereunder may be taken by J.P. Morgan
Securities LLC on behalf of the Underwriters, and any such action taken by J.P. Morgan Securities LLC shall be binding upon the Underwriters. 

(b) Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or
transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representative c/o J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (fax: (212)-270-1063); Attention:
Lawrence Landry. Notices to the Company and Guarantors shall be given to it at 12377 Merit Drive, Suite 1700, Dallas, Texas 75251, (fax: (214) 706-3409); Attention: William L. Boeing, Vice President, General Counsel and Secretary. 

(c) Governing Law. This Agreement and any claim, controversy, or dispute arising under or related to this Agreement shall be governed by
and construed in accordance with the laws of the State of New York, without regard to conflicts of laws principles other than Sections 5-1401 and 5-1402 of the New York General Obligation Law that would require the application of the law of any
other state. 
 Service of any process, summons, notice or document by mail to such party’s address set forth above shall be effective service of
process for any suit, action or other proceeding arising out of or based upon this Agreement or the transactions contemplated hereby that directly relate to the offering of the Securities brought in any court of competent jurisdiction. 

The Company and the Guarantors further agree that nothing herein shall affect the Representative’s rights to effect service of process in any other
manner permitted by law or to bring a suit, action or proceeding (including a proceeding for enforcement of a judgment) in any other court or jurisdiction in accordance with applicable law. 

(d) Submission to Jurisdiction. The Company and each of the Guarantors hereby submit to the exclusive jurisdiction of the U.S. federal
and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Company and each of the Guarantors waive any objection
which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. Each of the Company and each of the Guarantors agrees that a final judgment in any such suit, action or proceeding brought in such court shall
be conclusive and binding upon the Company and each Guarantor, as applicable, and may be enforced in any court to the jurisdiction of which Company and each Guarantor, as applicable, is subject by a suit upon such judgment. 

  
 30 








 (e) Waiver of Jury Trial. Each of the parties hereto hereby waives any right to trial by
jury in any suit or proceeding arising out of or relating to this Agreement. 
 (f) Counterparts. This Agreement may be signed in
counterparts (which may include counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. 

(g) Amendments or Waivers. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure
therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. 
 (h) Headings. The
headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. 

  
 31 








 If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below. 
  

			
	Very truly yours,
	
	EXCO RESOURCES, INC.
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO SERVICES, INC.
		
	By:	 	 /s/ William L. Boeing_

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO PARTNERS GP, LLC
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO GP PARTNERS OLD, LP
	
	 By: EXCO PARTNERS GP, LLC
 Its:
General Partner

		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary


 [Underwriting Agreement Signature Page] 







 
			
	EXCO PARTNERS OLP GP, LLC
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO OPERATING COMPANY, LP
	
	By: EXCO PARTNERS OLP GP, LLC
	Its: General Partner
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO MIDCONTINENT MLP, LLC
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO HOLDING (PA), INC.
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO PRODUCTION COMPANY (PA), LLC
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary



  
 [Underwriting Agreement
Signature Page] 








 
			
	EXCO PRODUCTION COMPANY (WV), LLC
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO EQUIPMENT LEASING, LLC
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO RESOURCES (XA), LLC
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO LAND COMPANY, LLC
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary
	
	EXCO HOLDING MLP, INC.
		
	By:	 	 /s/ William L. Boeing

	Name:	 	William L. Boeing
	Title:	 	Vice President, General Counsel and Secretary



  
 [Underwriting Agreement
Signature Page] 









			
	Accepted: April 11, 2014
	
	J.P. MORGAN SECURITIES LLC
	
	For itself and on behalf of the several Underwriters listed in Schedule 1 hereto.
		
	By:	 	 /s/ Larry Landry

		 	Authorized Signatory


  
 [Underwriting Agreement
Signature Page] 








 Schedule 1 
  

					
	 Underwriter
	  	Principal Amount	 
	 J.P. Morgan Securities LLC
	  	$	155,000,000	  
	 Wells Fargo Securities, LLC
	  	 	80,000,000	  
	 Merrill Lynch, Pierce, Fenner & Smith Incorporated
	  	 	62,500,000	  
	 BMO Capital Markets Corp.
	  	 	62,500,000	  
	 Credit Suisse Securities (USA) LLC
	  	 	25,000,000	  
	 ING Financial Markets LLC
	  	 	25,000,000	  
	 UBS Securities LLC
	  	 	25,000,000	  
	 Natixis Securities Americas LLC
	  	 	25,000,000	  
	 Capital One Securities, Inc.
	  	 	10,000,000	  
	 CIT Capital Securities LLC
	  	 	10,000,000	  
	 Deutsche Bank Securities Inc.
	  	 	10,000,000	  
	 Goldman, Sachs & Co.
	  	 	10,000,000	  
		  	  
	  
	 
	 Total
	  	$	500,000,000	  








 Schedule 2 

Guarantors 
 EXCO Services, Inc. 

EXCO Partners GP, LLC 
 EXCO GP Partners Old, LP 

EXCO Partners OLP GP, LLC 
 EXCO Operating Company, LP 

EXCO Midcontinent MLP, LLC 
 EXCO Holding (PA), Inc. 

EXCO Production Company (PA), LLC 
 EXCO Production Company (WV),
LLC 
 EXCO Equipment Leasing, LLC 
 EXCO Resources (XA), LLC

 EXCO Land Company, LLC 
 EXCO Holding MLP, Inc. 







 Schedule 3 

Subsidiaries 
 EXCO Services, Inc. 

EXCO Equipment Leasing, LLC 
 EXCO Partners GP, LLC 

EXCO GP Partners Old, LP 
 EXCO Partners OLP GP, LLC 

EXCO Operating Company, LP 
 EXCO Midcontinent MLP, LLC 

EXCO Holding (PA), Inc. 
 EXCO Production Company (PA), LLC 

EXCO Production Company (WV), LLC 
 EXCO Resources (XA), LLC 

Black Bear Gathering, LLC 
 EXCO Land Company, LLC 

EXCO Holding MLP, Inc. 
 Joint Ventures

 EBG Resources, LLC 
 EXCO Resources (PA), LLC 

Appalachia Midstream, LLC 
 Bonchasse Land Company, LLC 

PCMWL, LLC 
 Moran Minerals, L.L.C. 

Moran Land Company, L.L.C. 
 EXCO/HGI GP, LLC 

EXCO/HGI Production Partners, LP 







 Annex B 

Time of Sale Information 
 Final pricing term sheet
substantially in the form of Annex C attached hereto. 







 Annex C 

Issuer Free Writing Prospectus dated April 11, 2014 

Filed pursuant to Rule 433 under the Securities Act of 1933 

Supplementing the preliminary prospectus supplement dated April 8, 2014 to the prospectus, dated April 8, 2014 

Registration Statement on Form S-3 (File No. 333-195126) 

Pricing Term Sheet 

EXCO Resources, Inc. 

$500,000,000 
 8.500%
Senior Notes due 2022 
 This pricing term sheet supplements the preliminary prospectus supplement dated April 8, 2014 to the prospectus dated
April 8, 2014 (together, the “Preliminary Prospectus”) of EXCO Resources, Inc. This pricing term sheet relates only to the securities described below and is qualified in its entirety by reference to the Preliminary Prospectus. Terms
used and not defined herein have the meanings assigned in the Preliminary Prospectus. 
  

			
	Issuer:	  	EXCO Resources, Inc.
		
	Security description:	  	8.500% Senior Notes due 2022
		
	Distribution:	  	SEC Registered
		
	Offering size:	  	$500,000,000
		
	Gross proceeds:	  	$500,000,000
		
	Net proceeds (before expenses):	  	$491,250,000
		
	Maturity date:	  	April 15, 2022
		
	Coupon:	  	8.500%
		
	Interest Payment Dates:	  	April 15 and October 15, beginning on October 15, 2014. Interest will accrue from April 16, 2014.
		
	Price:	  	100.000% of principal amount
		
	Yield to maturity:	  	8.500%
		
	Spread to Benchmark Treasury:	  	+611 basis points
		
	Benchmark Treasury:	  	UST 1.75% due May 15, 2022
		
	Equity Clawback:	  	Up to 35% at 108.500% plus accrued and unpaid interest
		
	Until:	  	April 15, 2017









					
	Optional redemption:	  	On and after April 15, 2017, at the prices set forth below (expressed as percentages of the principal amount), plus accrued and unpaid interest:
			
	 	  	 Year
	  	 Percentage

		  	2017	  	106.375%
		  	2018	  	104.250%
		  	2019	  	102.125%
		  	2020 and thereafter	  	100.000%
		
	Make-whole call:	  	T+50 bps prior to April 15, 2017
		
	Change of control:	  	Putable at 101% of principal plus accrued and unpaid interest
		
	Trade date:	  	April 11, 2014
		
	Settlement:	  	T+3; April 16, 2014
		
	CUSIP number:	  	269279 AE5
		
	ISIN number:	  	US269279AE58
		
	Denominations/Multiple:	  	$2,000 x $1,000
		
	Joint Book-Running Managers:	  	J.P. Morgan Securities LLC
		  	 Wells Fargo Securities, LLC
 Merrill
Lynch, Pierce, Fenner & Smith Incorporated
 BMO Capital Markets Corp.

		
	Senior Co-Managers:	  	 Credit Suisse Securities (USA) LLC

ING Financial Markets LLC
 UBS Securities LLC

Natixis Securities Americas LLC

		
	Co-Managers:	  	 Capital One Securities, Inc.
 CIT
Capital Securities LLC
 Deutsche Bank Securities Inc.
 Goldman,
Sachs & Co.


 CHANGES TO THE PRELIMINARY PROSPECTUS 

Ratio of earnings to fixed charges 
 For the year
ended December 31, 2013, the Issuer’s pro forma ratio of earnings to fixed charges would have been 1.2x, after giving effect to the completion of the offering and the application of the net proceeds therefrom. 

Increase in principal amount offered 
 The Issuer
has increased the size of the offering such that the principal amount of the notes offered has increased from $400.0 million aggregate principal amount to $500.0 million aggregate principal amount. 

All figures presented as giving effect to the offering, including net proceeds from the offering, cash and cash equivalents, long-term debt and total
capitalization are adjusted accordingly to give effect to the increase in the offering size and an assumed use of the net proceeds to repay the term loan and a portion of the revolving commitment under the EXCO Resources Credit Agreement. 







 The Issuer estimates that the proceeds from this offering, after deducting estimated discounts to the
underwriters and offering fees and expenses, will be approximately $490.0 million. 
 As of March 31, 2014, after giving effect to the completion of
the offering and the application of the net proceeds therefrom and the expected borrowing base redetermination, the borrowing base under the EXCO Resources Credit Agreement would have been $875.0 million. 

After giving effect to the completion of this offering and the application of net proceeds therefrom and the expected borrowing base redetermination, as of
March 31, 2014, the Issuer would have had approximately $1.4 billion of total indebtedness (including the notes), of which: 
  

	 	•	 	the Issuer would have had approximately $1.3 billion of unsecured indebtedness (including the notes), which would have ranked equally with the notes; and 


 

	 	•	 	the Issuer would have had approximately $183.7 million of secured indebtedness under the EXCO Resources Credit Agreement to which the notes will be effectively subordinated, excluding $6.9 million of outstanding letters
of credit, and the Issuer would have had total unused availability of approximately $684.4 million under the EXCO Resources Credit Agreement. 


Capitalization 
 As of December 31, 2013, on
an as further adjusted basis to reflect the completion of this offering and the application of net proceeds therefrom: 
  

	 	•	 	the Issuer’s cash and cash equivalents would have been $66.5 million; 

  

	 	•	 	the Issuer’s total long-term debt would have been $1.5 billion; and 

  

	 	•	 	the Issuer’s total capitalization would have been $1.9 billion. 

 Variable rate indebtedness and
interest rate risk 
 As of March 31, 2014, after giving effect to the completion of the offering and the application of the use of proceeds
therefrom, the Issuer expects that its total interest expense, excluding amortization of deferred financing costs and its proportionate share of interest expense for the EXCO/HGI Partnership, on an annual basis based on currently available interest
rates would change by approximately $1.8 million for every 1% change in interest rates. 
 Description of the notes 

The following changes are being made to the “Description of the notes” section of the preliminary prospectus supplement: 

Certain covenants—Restricted Payments 
 On p.
69, the disclosure is amended by deleting the following text “; plus (E) $500.0 million” and inserting a period at the end of clause (D) on p. S-68. 

The foregoing sentence on page S-69 (and elsewhere in the preliminary prospectus supplement where similar information appears) is hereby amended as follows:

 “As of December 31, 2013, the total amount available under the foregoing clause (3) would have been approximately $197.5 million, or
approximately $470.5 million after giving effect to the Rights Offering.” 
 Correlative changes to relevant sections of the Preliminary Prospectus are
hereby deemed made in a manner consistent with the foregoing. 







  

The Issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you
invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these
documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free
1-800-245-8812. 
 This communication should be read in conjunction with the preliminary prospectus supplement, dated April 8, 2014, and the
accompanying prospectus, dated April 8, 2014. 
 Any disclaimer or other notice that may appear below is not applicable to this communication and
should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.